Page 9 - Export 10
P. 9
ACTOVEGROUP
Iran’s favorable condition in the production of Active Pharmaceutical Ingredients (APIs) has caused more than %69 of the country's With more than 4,500 active personnel working in 10 rms, activities of the Actover group can be classi ed into two separate
pharmaceutical needs to be produced domestically. APIs due to their scienti c chemical processes and their relatively high costs are often elds of food industry and pharmaceutics. The pharmaceutical branch of Actover group comprises companies: Actoverco,
produced by two countries, India and China. Clearly, the quality of the APIs is the most important factor in the quality and e ectiveness of Actero Middle East, Atipharmed, Alborz Zagros, and Actobiochem. Commodity bundle of Actover pharmaceutical group
the nal medicine; a subject which is commonly associated with the negligence of most of the producers in Iran. includes more than 330 products of active pharmaceutical ingredients (APIs) as well as of 16 various therapeutic elds covering
cardiovascular, neurology, psychiatry, respiratory diseases, diabetes, gastrointestinal disorders, urology, gynecology and
Except for a few of the great chemistry scientists of the country, the rest of the producers have not made any e orts to maintain the quality infertility, Multiple Sclerosis (MS), organ transplant, dermatology and cosmetics, oncology, analgesics, infective diseases, and
of their products at the global level. This factor has been the reason for the impossibility of exporting Iranian medicines to other countries. supplements.
Therefore, Actover group by considering the economical conditions of the country and the impossibility of using government’s currency for
importing quality products with the global standards decided to start its Active Pharmaceutical Ingredients manufacturing plant in order Subsequent to a vast investment aiming at producing the highest quality drugs, Actover group currently owns some of the
to use those APIs in its pharmaceutical products which could compete with the world’s largest manufacturers in terms of quality and global most unique and modern drug manufacturing facilities in Iran. Among some of the exclusive features of the Actover
standards. At the same time, those APIs can meet the needs of those pharmaceutical manufacturers who need to improve the quality of pharmaceutical group are: the only company bearing OEB5 standard certi cate to manufacture hazardous drugs (Alborz
their products in order to enter the global markets. Zagros company), the most advanced plant making anticancer drugs (Actero), the only single use bioreactors in Iran (Actoverco
BioTech factory), and the rst factory speci cally designed for production of hormonal medications (Atipharmed). With a
The transfer of world-class technology in the manufacturing and processing of APIs is one of the biggest achievements that has never backbone of more than 2500 manpower in di erent departments covering research and development, manufacturing,
been seen in the country before, and generally, the related science available to other API manufacturers in Iran do not conform to the marketing, drug distribution, and with the support of an extensive experience spanning more than a half-century, Actover
world needs. Therefore, the opening of the Active Pharmaceutical Ingredients manufacturing plant of Actover group named Actobiochem, group is considered one of the greatest pharmaceutical groups in the country. By utilizing quality raw materials, most recent
in addition to the technology transfer of complex manufacturing processes of APIs to the country, enable us to produce word quality cutting-edge technology, and immense knowledge of Iranian pharmaceutical scientists, the group represents premium grade
products with global standard which can compete with the world’s largest pharmaceutical companies for our beloved country, Iran. This drugs meeting all international standards.
utmost importance will occur with the help of Almighty God and the e orts and follow-ups of Iranian valuable experts.
IRANIAN DETERMINATION
VALSARTAN ATORVASTATIN CALCIUM ROSUVASTATIN CALCIUM GLOBAL TECHNOLOGY
GABAPENTIN NITROGLYCERIN GRANULE METFORMIN
BORTEZOMIB ZOLEDRONIC ACID CAPECITABINE
EMPAGLIFLOZIN VILDAGLIPTIN LINAGLIPTIN
DAPAGLIFLOZIN SITAGLIPTIN LEVOFLOKSASIN